Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

被引：0
|
作者：
Landau, AO
Batisse, DP
van Huen, PD
Piketty, C
Bloch, F
Pialoux, G
Petite, JP
Weiss, L
Kazatchkine, M
机构：
[1] Hosp Broussais, Paris, France
[2] Hosp Rothschild, Paris, France
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
828
引用
收藏
页码：367A / 367A
页数：1
相关论文
共 50 条
  • [21] Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C
    Pérez-Olmeda, M
    González, J
    García-Samaniego, J
    Arribas, JR
    Soriano, V
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (03) : 308 - 309
  • [22] EFFICACY AND SAFETY OF ALPHA-INTERFERON TREATMENT FOR CHRONIC HEPATITIS-C IN HIV-INFECTED PATIENTS
    SORIANO, V
    GARCIASAMANIEGO, J
    BRAVO, R
    CASTRO, A
    ODRIOZOLA, PM
    GONZALEZ, J
    COLMENERO, M
    CARBALLO, E
    SUAREZ, D
    LLIBRE, JM
    ALBERDI, JC
    PEDREIRA, J
    GONZALEZLAHOZ, J
    LOPEZCALVO, S
    GONZALEZANGLADA, I
    VAZQUEZ, J
    DELROMERO, J
    RODRIGUEZ, C
    GARCIA, S
    MORENO, A
    FERNANDEZCRUZ, E
    ZABAY, JM
    COSIN, J
    TOR, J
    MUGA, R
    BARRIO, E
    MARTINEZVAZQUEZ, J
    SANTAMARIA, JM
    RODRIGUEZPINERO, J
    MUNOZ, F
    [J]. JOURNAL OF INFECTION, 1995, 31 (01) : 9 - 13
  • [23] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    [J]. Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [24] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [25] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    [J]. HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [26] Severe intraocular complications of interferon-alpha and ribavirin therapy in patients with chronic viral hepatitis C
    Sène, D
    Bodaghi, B
    Saadoun, D
    Touitou, V
    Perlemuter, G
    Cassoux, N
    Piette, JC
    Hoang, PL
    Cacoub, P
    [J]. HEPATOLOGY, 2004, 40 (04) : 330A - 330A
  • [27] Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin
    Bhagani, Sanjay
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 483 - 490
  • [28] Therapy with pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
    Romero, M
    Nunez, M
    Perez-Olmeda, M
    Gonzalez, J
    Castro, A
    Arribas, JR
    Barreiro, P
    Soriano, V
    Garcia-Samaniego, J
    [J]. HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [29] Efficacy of interferon-alpha 2b in combination with ribavirin in the treatment of non-responder patients with chronic hepatitis C: A randomised-controlled trial.
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Paraskevas, E
    Avgerinos, A
    Kanatakis, S
    Vaffiadis, I
    Delladetsima, J
    Demonakou, M
    Sypsa, V
    Hatzakis, A
    [J]. HEPATOLOGY, 1999, 30 (04) : 632A - 632A
  • [30] Interferon therapy of chronic hepatitis C in HIV-infected patients
    Paesa, CR
    Garces, PA
    Catalan, AP
    Lazcano, IH
    Errasti, JMA
    [J]. REVISTA CLINICA ESPANOLA, 1998, 198 (04): : 221 - 225
12345